Detalles de la búsqueda
1.
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human use.
Oncologist
; 20(2): 196-201, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25616431
2.
Experimental Models for Cold Exposure of Muscle in vitroand in vivo.
Bio Protoc
; 12(13): e4461, 2022 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35937928
Resultados
1 -
2
de 2
1
Próxima >
>>